Acesso livre
Acesso livre

Medicina de Emergências

Editorial | 20 recomendações para individualizar intervenções na ressuscitação precoce de pacientes com sepse.

19 Nov, 2021 | 12:20h

Twenty recommendations to individualize interventions in the early resuscitation of patients with sepsis – Critical Care

Conteúdo relacionado: Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.


Estudo randomizado | Imunoglobulinas intravenosas não melhoram os desfechos em pacientes com síndrome da angústia respiratória aguda moderada a grave associada a COVID-19.

16 Nov, 2021 | 12:47h

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial – The Lancet Respiratory Medicine

 

Comentário no Twitter

 


Revisão | Trombocitopenia trombótica imune induzida por vacina.

16 Nov, 2021 | 12:46h

Vaccine-induced immune thrombotic thrombocytopenia – The Lancet Haematology

Conteúdos relacionados:

Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.

Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.

Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis.

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.

Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)

 

Comentário no Twitter

 


Consenso internacional 2021 sobre ressuscitação cardiopulmonar e cuidado cardiovascular de emergência com recomendações de tratamento.

16 Nov, 2021 | 12:36h

2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and Teams; First Aid Task Forces; and the COVID-19 Working Group – Circulation (para versão HTML, clique aqui)

Principais tópicos a saber: International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (CoSTR) – American Heart Association


Revisão | Solução de problemas dos dispositivos cardíacos na UTI.

16 Nov, 2021 | 12:24h

Cardiac device troubleshooting in the intensive care unit: an educational review – European Heart Journal. Acute Cardiovascular Care

 

Comentário no Twitter

 


Estudo de coorte sugere que tomografia computadorizada com dose baixa vs. dose padrão de radiação têm acurácia diagnóstica similar na suspeita de apendicite aguda.

15 Nov, 2021 | 13:39h

Comunicado de imprensa: Doctors can use CT scans with less radiation to diagnose appendicitis – Oxford University

Estudo original: Diagnostic accuracy using low-dose versus standard radiation dose CT in suspected acute appendicitis: prospective cohort study – British Journal of Surgery (link para o resumo – $ para o texto completo)


Estudo observacional | Em pacientes com parada cardíaca com ritmo sugerindo necessidade de choque no hospital, epinefrina antes da desfibrilação foi associada com pior sobrevida.

15 Nov, 2021 | 13:35h

Epinephrine before defibrillation in patients with shockable in-hospital cardiac arrest: propensity matched analysis – The BMJ

 

Comentário no Twitter

 


Diretrizes ASA 2022 para o tratamento de via aérea difícil.

12 Nov, 2021 | 13:40h

2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway – Anesthesiology

Conteúdos relacionados:

Consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient.

Difficult airway management in neonates and infants: knowledge of devices and a device-oriented strategy.

Consensus Guideline: Pediatric Airway Management in COVID-19 Patients

Guidelines for Awake Tracheal Intubation in Adults

Position Paper: Management of Unanticipated Difficult Airways in Children in Anesthetic Practice

Review: Difficult Airway Management Algorithms (várias fontes sobre o tema)

The Difficult Airway Trolley: A Narrative Review and Practical Guide


Diretrizes ERS | Cânula nasal de alto fluxo na insuficiência respiratória aguda.

12 Nov, 2021 | 13:38h

ERS Clinical Practice Guidelines: High-flow nasal cannula in acute respiratory failure – European Respiratory Journal


Pílulas antivirais contra COVID: o que os cientistas ainda precisam saber – “Medicações como molnupiravir e paxlovid podem mudar o curso da pandemia se os resultados de ensaios clínicos se repetirem no mundo real.”

11 Nov, 2021 | 16:23h

COVID antiviral pills: what scientists still want to know – Nature

Conteúdos relacionados:

[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.

A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm.

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.